HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The high density lipoprotein- and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects.

Abstract
Tangier disease (also known as familial HDL-deficiency) is characterized by very low high density lipoprotein (HDL) plasma levels, splenomegaly, and massive cholesteryl ester accumulation in the cytoplasm of various cell types. Since this phenotype may in part be caused by a defect in the pathway mediating cholesterol efflux from peripheral cells, we investigated the HDL3-mediated mobilization of cholesterol synthesized de novo from [14C]-mevalonolactone in cultivated fibroblasts from two patients with Tangier disease. Our results indicate that the HDL3-induced translocation of [14C]-cholesterol from intracellular pools to the plasma membrane and its subsequent secretion into the extracellular medium was approximately 50% less in the cells from the patients than in controls. The same result was also obtained with artificial apolipoprotein A-I-containing phospholipid vesicles. By contrast, no significant difference in HDL3-induced cholesterol efflux was observed when plasma membrane was labeled with exogenous [14C]-cholesterol. We conclude that inefficient cholesterol efflux in Tangier disease is primarily caused by impaired HDL3-induced activation of cholesterol translocation from intracellular pools to the plasma membrane.
AuthorsM Walter, U Gerdes, U Seedorf, G Assmann
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 205 Issue 1 Pg. 850-6 (Nov 30 1994) ISSN: 0006-291X [Print] United States
PMID7999122 (Publication Type: Journal Article)
Chemical References
  • Apolipoprotein A-I
  • Lipoproteins, HDL
  • 1,2-Dipalmitoylphosphatidylcholine
  • Cholesterol
Topics
  • 1,2-Dipalmitoylphosphatidylcholine (metabolism)
  • Apolipoprotein A-I (metabolism)
  • Biological Transport
  • Cell Membrane (metabolism)
  • Cholesterol (metabolism)
  • Fibroblasts (metabolism)
  • Humans
  • Lipoproteins, HDL (metabolism)
  • Tangier Disease (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: